Auricular Point Acupressure Combined with Compound Lidocaine Cream to Manage Arteriovenous Fistula Puncture Pain: A Multicenter Randomized Controlled Trial
Table 2
Comparison of clinical characteristics of the study sample (n = 120, n, %).
Variable
Control (n = 30)
CLC (n = 30)
APA (n = 30)
APA + CLC (n = 30)
χ2
Primary disease
Hypertension
11 (36.67)
8 (26.67)
10 (33.33)
9 (30.00)
1.498
0.997
Diabetes
10 (33.33)
12 (40.00)
10 (33.33)
10 (33.33)
Nephropathy
8 (26.67)
9 (30.00)
9 (30.00)
9 (30.00)
Other
1 (3.33)
1 (3.33)
1 (3.33)
2 (6.67)
Complications
0
3 (10.00)
4 (13.33)
3 (10.00)
5 (16.67)
1.982
0.992
1
14 (46.67)
15 (50.00)
16 (53.33)
12 (40.00)
2
7 (23.33)
7 (23.33)
6 (20.00)
7 (23.33)
≥3
6 (20.00)
4 (13.33)
5 (16.67)
6 (20.00)
Dialysis duration (years)
＜1
7 (23.33)
7 (23.33)
6 (20.00)
8 (26.67)
0.764
0.993
1∼2
11 (36.67)
13 (43.33)
12 (40.00)
11 (36.67)
≥3
12 (40.00)
10 (33.33)
12 (40.00)
11 (36.67)
AVF use experiences (month)
＜6
6 (20.00)
8 (26.67)
7 (23.33)
8 (26.67)
1.836
0.994
6∼
7 (23.33)
8(26.67)
8 (26.67)
9 (30.00)
12∼
10 (33.34)
10 (33.34)
9 (30.00)
8 (26.67)
≥36
7 (23.33)
4 (13.33)
6 (20.00)
5 (16.67)
CLC = compound lidocaine cream; APA = auricular point acupressure; PHC = physiological comfort; PSC = psychological comfort; SC = social comfort; EC = environmental comfort.
